Thiol-Activated HNO Release from a Ruthenium Antiangiogenesis Complex and HIF-1a Inhibition for Cancer Therapy. (2016)
Attributed to:
Warwick Centre for Analytical Science
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acschembio.6b00222
PubMed Identifier: 27191177
Publication URI: http://europepmc.org/abstract/MED/27191177
Type: Journal Article/Review
Volume: 11
Parent Publication: ACS chemical biology
Issue: 7
ISSN: 1554-8929